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Abstract: A total of 302 bacterial strains were isolated from 43 raw milk samples collected 
from dairy farms in Chiang Mai province. Out of these strains isolated, three strains were 
found to produce bacteriocins against Streptococcus dysgalactiae DMST10953, a bovine 
mastitis  pathogen.  These  were  Lactobacillus  fermentum  RMM701,  Streptococcus  bovis 
RMM703 and Streptococcus bovis RMM902, which exhibited bacteriocin activity at 40, 40 
and 20 AU/ml respectively. Bacteriocins produced by these three strains were heat-stable up 
to 80 
oC. Bacteriocins produced by L. fermentum RMM701 and S. bovis RMM902 were 
stable at pH 2.0 - 7.0 while that from S. bovis RMM703 was stable at pH 2.0 - 6.0. These 
bacteriocins were also found to be inactivated by proteolytic enzymes such as proteinase K 
and subtilisin A. 
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Introduction 
 
  Bovine mastitis is an inflammation of the mammary glands usually due to a microbial infection 
that affects milk production and quality, being one of the most significant causes of economic loss to 
the dairy industry [1]. Staphylococcus aureus, Streptococcus dysgalactiae and Streptococcus uberis are still 
the  dominant  pathogens  [2].  Bovine  mastitis  is  usually  treated  or  prevented  with  intramammary  
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antibiotics [3,4]. Although the use of antibiotics to control mastitis is normally very effective, it has 
some disadvantages,  including the appearance of residues  in the  milk of treated cows [5] and the 
perceived  connection  to  the  emergence  of  antibiotic-resistant  human  pathogens,  particularly  the 
increased  incidence  of  organisms  such  as  methicillin-resistant  St.  aureus,  which  is  prevalent  in 
nosocomial infections in humans [6]. Thus the identification of alternative methods for controlling this 
illness is essential. One of these methods could be the use of bacteriocin. 
  Bacteriocins  are  proteinaceous  antimicrobial  agents  and  inhibit  or  kill  closely  related 
species of bacteria [7]. Some bacteriocins inhibit food spoilage and pathogenic microorganisms. They 
are therefore potentially useful as natural replacements for synthetic food preservatives or used in such 
medical and veterinary applications as the prevention and treatment of some infectious diseases [8,9]. 
  In a previous study, nisin produced by Lactococcus lactis is effective against a wide range of 
Gram-positive bacteria, including mastitic pathogens such as St. aureus ATCC 2970, S. dysgalactiae 
ATCC 27957, and S. uberis ATCC 27958 [10]. In addition, when teat seal was blended with  lacticin 
3147 produced by Lc. lactis and infused into teats of nonlactating cows, the formulation reduced the 
incidence of clinical mastitis in teats that had been inoculated with S. dysgalactiae from 42% in control 
quarter to 6% in treated quarters [11]. 
  The aims of this study are to screen bacteriocin-producing bacteria capable of inhibiting the 
growth  of    bovine  mastitis  pathogens  and  to  study  the  physicochemical  characteristics  of  these 
bacteriocins.  
 
 
Materials and Methods 
 
Bacterial strains and culture conditions  
 
  Three hundred and two bacterial strains were isolated from 43 raw milk samples in Chiang Mai 
province and used in the screening for bacteriocin production. St. aureus RMB203 and St. aureus 
RMB1601, were isolated from bovine mastitis. S. dysgalactiae DMST 10953 and S. agalactiae DMST 
11366 were used as indicators. All lactic acid bacteria were cultivated in De Man, Rogosa and Sharpe 
(MRS) medium and incubated anaerobically at 37 
oC for 16 h in anaerobic jars having a H2+CO2 
environment generated with a BBL GasPak (Becton Dickinson Microbiology systems). Other non-
lactic acid bacteria were grown in Brain Heart Infusion (BHI) medium at 37 
oC for 16 h under aerobic 
condition. The bacteria were stored at -80 
oC in 20% glycerol until needed. 
 
Initial screening of bacteriocin-producing bacteria 
 
The bacteriocin-producing bacteria were initially screened by spot agar test [12]. A total of 302 
bacterial strains were grown in their appropriate culture medium and conditions: lactic acid bacteria 
were cultivated in MRS medium and incubated anaerobically at 37 
oC for 16 h, and other non-lactic 
acid bacteria were grown in BHI medium at 37 
oC for 16 h under aerobic condition. These bacteria 
was spotted onto BHI agar plate. After 16 h of incubation at 37 
oC in aerobic condition, the plates were  
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overlayed with soft BHI agar (0.7 % agar) containing indicator cultures. The plates were incubated 
overnight at 37 
oC to assess the activity of these bacteria against each indicator strain. 
 
Preparation of bacteriocin samples 
 
Bacterial strains were cultivated in their appropriate culture medium and conditions. Extraction 
of bacteriocin was carried out using the method of Schillinger and Lucke [12]. Cells were removed by 
centrifugation at 5,000 rpm for 10 minutes at 4 
oC. The supernatant were adjusted to pH 6.5 with 5M 
NaOH  and  5M  HCl  to  exclude  the  antimicrobial  effect  of  organic  acids.  Inhibitory  activity  from 
hydrogen peroxide was eliminated by the addition of 1 mg/ml catalase, followed by filtration of the 
supernatant through a 0.2 µm pore-size nylon syringe filter. Supernatants were stored at -20 
oC.  
 
Bacteriocin bioassay 
 
Antimicrobial activity against indicator organisms was determined using a well diffusion assay 
[12]. Pre-poured BHI agar plates were overlaid with BHI soft agar containing indicator cultures. Wells 
of  6  mm  in  diameter  were  cut  into  the  agar  plate  with  a  cork  borer  and  50  µl  of  the  cultured 
supernatant  fluid  was  placed  into  each  well.  The  plates  were  incubated  overnight  at  37 
oC.  The 
antimicrobial activity of the bacteriocin is defined as the reciprocal of the highest dilution showing 
inhibition of the indicator lawn and is expressed in activity units per ml (AU/ml). 
 
Identification of bacterial strains 
 
  Biochemical characteristics: Bacterial strains were cultivated in MRS medium and incubated 
anaerobically at 37 
oC for 16 h. Sugar fermentation reactions were recorded by using the API 50 CH 
and API 20 STREP (BioMérieux).  
Extraction, amplification and sequencing of bacterial DNA: DNA extraction was conducted by 
using the commercial Isoplant DNA extraction kit (NO. 314-02731, Nippon Gene, Japan) with the 
manufacturer’s  protocol.  Extracted  DNA  was  stored  at  -20  °C  until  needed.  The  16S  rDNA  was 
amplified  by  polymerase  chain  reaction  (PCR)  using  the  primers  27F  (5’-
AGAGTTTGATCCTGGCTCAG-3’)  and  520R  (5’-ACCGCGGCKGCTGGC-3’)  (Operon, 
Germany).  PCR  was  performed  in  a  PCR  Sprint  Thermal  Cycler  (Sprint,  Thermal  hybrid).  For  each 
reaction, a 50-μl reaction mixture was prepared. It consisted of 25 μl of Qiagen master mix, 2 μl of  27F 
primer, 2 μl of 520R primer, 20 μl of sterile H2O, and 1 μl of 20 ng/ μl bacterial DNA. The amplification 
was programmed as follows: initial denaturation at 94
 oC for 5 min, followed by 25 cycles at 94 
oC for 
1 min, 55 
oC for 1 min, and 72 
oC for 1 min. After these cycles, the reaction was maintained at 72 
oC 
for  5  min  and  then  cooled  to  4 
oC.  Five  microlitres  of  the  PCR  products  were  visualised  after 
electrophoresis  in  a  1.5  %  agarose  gel  and  were  subsequently  visualised  by  UV  illumination  after 
ethidium bromide staining. The PCR products were purified by using the TaKaRa SUPREC
TM-PCR 
(Takara,  Japan)  according  to  the  manufacturer’s  instructions,  and  analysis  of  all  sequences  was 
performed by First Base Laboratories Company (Malaysia).  
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Sequence  data  analysis:  All  of  the  sequencing  data  were  analysed  with  the  BLAST  (The 
National Centre for Biotechnology Information; NCBI). 
 
Characterisation of bacteriocin 
 
  The  bacteriocin  samples  were  characterised  with  respect  to  heat,  pH  stability  and 
susceptibility to denaturation by enzymes. 
  Heat resistance: Samples of bacteriocin were exposed to various heat treatments: 40, 60, 80, 
100 and 121ºC. Aliquot volumes were then removed after 0, 30, 60 and 90 minutes [13] and assayed 
for bacteriocin activity. 
pH sensitivity: Samples of bacteriocin were adjusted to pH 2, 4, 6, 8, 10, and 12 with 5N HCl 
or 5N NaOH. After incubating for 4 h at room temperature the bacteriocin samples were adjusted to 
pH 6.5 [13] and assayed for bacteriocin activity. 
Enzyme treatment: The sensitivity of the bacteriocin to different enzymes was checked. The 
cell-free supernatant fluid at pH 6.5 was treated separately with protease and proteinase K at a final 
concentration of 1.0 mg/ml. Samples of  bacteriocin were incubated with each enzyme for 2 h at 37 ºC. 
After that samples of  bacteriocin were heated for 5 minutes at 100 
oC to inactivate enzyme activity 
[14] and assayed for bacteriocin activity. 
 
Results and Discussion 
 
Isolation of bacteria and screening of bacteriocin producing bacteria 
 
  A total of 302 bacterial strains were isolated from 43 raw milk samples in Chiang Mai province. 
These  isolates  were  tested  for  antimicrobial  activity  against  4  indicator  strains.  Only  148  strains 
showed inhibition zones when they were analysed by the spot agar test. Out of these strains, only three 
strains  (RMM701,  RMM703  and  RMM902)  produced  bacteriocins  against  S.  dysgalactiae  DMST 
10953, which is a bovine mastitis pathogen, when cell-free supernatants were analysed by the well-
diffusion assay. Figure 1 shows the sizes of the inhibition zone against S. dysgalactiae when 10% (v/v) 
lactic  acid  was  used  as  positive  control.  Bacteriocins  produced  by  these  three  strains  exhibited 
bacteriocin activity at 40, 40 and 20 AU/ml respectively (Table 1). 
 
Table  1.    Activity  of  bacteriocin  produced  by  three  bacterial  strains  against  Streptococcus  
dysgalactiae DMST 10953  
 
Strain  Inhibition zone (mm)*  Bacteriocin activity 
(AU/ml) 
Positive control                        12.4 + 0.6  - 
RMM701  9.3 + 0.6   40 
RMM703  9.7 + 0.6  40 
RMM902  9.7 + 0.6  20 
* well  = 6.0 mm  
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Figure 1.  Results of the well-diffusion assay of three bacterial strains which produced bacteriocins 
against Streptococcus dysgalactiae DMST10953. (The rest of three wells showed negative results.) 
 
 
Identification of bacterial strains 
 
  Strains  RMM701,  RMM703  and  RMM902  were  identified  as  Lactobacillus    fermentum, 
Streptococcus bovis and Streptococcus bovis by 75.8, 97.6 and 97.6% homology respectively,  based 
on  API  50  CH  and  API  20  STREP  (BioMérieux)  profiles  (not  shown)  and  their  physiological 
characteristics. The 16S rDNA was amplified from three bacterial strains. Fragments of about 500 bp 
were obtained (Figure 2.). The  16S rDNA sequence of RMM701, RMM703 and RMM902 were 
determined  and  compared  with  available  16S  rDNA  sequences  in  the  Genbank  database.  The 
sequences were similar to L. fermentum RMM701, S. bovis RMM703 and  S. bovis RMM902 by 99.1, 
98.9  and  99.4  %  homology  respectively  (Table  2).  Thus,  these  strains  were    chosen  for  further 
characterisation. 
 
M       1      2       3 
   
Figure 2.  Ethidium bromide-stained agarose gel electrophoresis of amplified 16S rDNA of bacterial 
strains.  Lane  M:  100  bp  DNA  ladder  used  as  molecular  size  marker;  lane  1:  RMM701;  lane  2: 
RMM703; lane 3: RMM902. 
   
RMM701 
     
 RMM703 
        
          RMM902 
 
      10 % (v/v) 
         lactic acid 
 
100 bp 
200 bp 
500 bp 
1,031 bp 
~ 500 bp  
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Table 2.  Identification of bacteriocin-producing bacteria by 16S rDNA sequencing* 
 
Bacterial 
strain 
Bacteria  Accession 
number 
Identity  % Homology 
RMM701  Lactobacillus fermentum  DQ523484.1  522/527  99.1 
RMM703  Streptococcus bovis  AB186306.1  525/531  98.9 
RMM902  Streptococcus bovis  DQ467871.1  482/485  99.4 
              * Analysis date : 10 August 2007 
 
Effects of temperature, pH and enzymes on the bacteriocin activity  
 
  The  effects  of  heat,  pH  and  enzymes  on  bacteriocin  activity  were  determined  using  S. 
dysgalactiae  DMST  10953  as  indicator  organism.  Bacteriocins  produced  by  the  three  strains 
(RMM701, RMM703 and RMM 902) were heat-stable at 80
oC for 60 min although their activities 
were reduced twofold. At 100 
oC there was no detectable bacteriocin activity in these three strains 
(Figure 3). Heat sensitivity of these bacteriocins may be due to their non-complex, linear structures. 
Similar results of heat sensitivity were recorded for bozacin 14 [15]. Most bacteriocins were  heat 
stable at 121
 oC  such as pediocin P [16], lactocin LC-09 [17] and nisin Z [18]. The heat stability may 
be  due  to  the  formation  of  small  globular  structures  and  the  occurrence  of  strongly  hydrophobic 
regions, stable cross-linkages, and a high glycine content [19].   
Bacteriocins produced by Leuconostoc sp. RMM701 and S. bovis RMM902 were stable at pH  
2-7, while that of S. bovis RMM703 was stable at pH 2-6 (Table 3). The loss of activity at higher pH 
could be due to change of conformation of the molecule.  This result was similar to the properties 
reported  for  bacteriocins produced by other lactic acid bacteria such as Pediocin AcH [20], Pediocin 
A [21], Lactacin [22], Nisin [23] and bovicin HC5 [24].  
These bacteriocins were inactivated by proteolytic enzymes such as proteinase K and protease 
(Table  4).  Inactivation  of  antimicrobial  activity  by  protease  and  proteinase  K  suggested  that  the 
substances could be antimicrobial peptides [16]. 
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Figure 3.  Effect of temperature  on the activity of  bacteriocin produced by each bacterial strain: (A) L.  
fermentum RMM701, (B) S.  bovis  RMM703,  and (C) S.  bovis  RMM902 
 
 
 
                
(A) 
(B) 
(C)  
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                Table 3.  Effects of pH on activity of bacteriocin produced by each bacterial strain 
 
 
Bacteriocin activity (AU/ml) 
 
pH   
L. fermentum 
RMM701 
 
 
S. bovis 
RMM703 
 
S. bovis 
RMM902 
2 
3 
4 
5 
6 
7 
8 
9 
10 
20 
20 
20 
20 
20 
20 
0 
0 
0 
20 
20 
20 
20 
20 
0 
0 
0 
0 
20 
20 
20 
20 
20 
20 
0 
0 
0 
 
                
               Table 4.  Effects of enzyme on activity of bacteriocin produced by each bacterial strain 
 
 
Bacteriocin activity (AU/ml) 
 
Enzyme   
L. fermentum 
RMM701 
 
 
S. bovis 
RMM703 
 
S. bovis 
RMM902 
Control*  
Proteinase K 
Subtilisin A 
40 
0 
0 
40 
0 
0 
20 
0 
0 
     * Crude extract of bacteriocins not treated with enzyme was used as control. 
 
Conclusions 
 
L. fermentum RMM701, S. bovis RMM703 and S. bovis RMM902 were isolated from raw 
milk  samples  from  dairy  farms  in  Chiang  Mai  province.  They  all  produced  bacteriocins  against 
Streptococcus  dysgalactiae  DMST10953,  a  bovine  mastitis  pathogen.  These  bacteria  exhibited 
bacteriocin activities at 40, 40 and 20 AU/ml respectively. Bacteriocins produced by these three strains 
were  heat-stable  up  to  80 
oC  for  60  minutes,  at  which  their  activities  were  reduced  twofold. 
Bacteriocins produced by L. fermentum RMM701 and S. bovis RMM902 were stable at pH 2.0 - 7.0 
while that from S.  bovis RMM703 was stable at pH 2.0 - 6.0. These bacteriocins were also found to be 
inactivated  by  proteolytic  enzymes  such  as  proteinase  K  and  subtilisin  A,  suggesting  that  the 
substances could be antimicrobial peptides.  
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